ctrl K

Price Alert

LENZ Therapeutics Inc. (LENZ)

NASDAQ: LENZ · Real-Time Price · USD

39.63

-2.35 (-5.60%)

At close: Sep 08, 2025, 3:32 PM

LENZ Therapeutics Revenue Breakdown

Period Ending	Jun 30, 2025
Reportable Segment Revenue	5M
Reportable Segment Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Selling, General, and Administrative Revenue	12.8M	11.11M	9.36M	6.48M	7.39M	5.55M	14.46M	10.49M	5.36M	5.4M	8.29M	7.85M	6.93M	5.82M	7.74M	5.36M	4.77M	3.9M	1.81M	1.45M	868K	121K
Selling, General, and Administrative Revenue Growth	+15.14%	+18.77%	+44.31%	-12.25%	+33.11%	-61.61%	+37.78%	+95.89%	-0.85%	-34.82%	+5.57%	+13.22%	+19.16%	-24.76%	+44.23%	+12.53%	+22.17%	+115.29%	+24.62%	+67.51%	+617.36%	n/a
Research and Development Revenue	9.06M	5.82M	5.87M	6.45M	6.95M	10.54M	1K	2.38M	13.51M	16.24M	16.24M	16.13M	17.78M	18.25M	11.21M	8.68M	12.67M	5.38M	6.39M	2.31M	423K	n/a
Research and Development Revenue Growth	+55.74%	-0.85%	-9.04%	-7.11%	-34.09%	+1053600.00%	-99.96%	-82.35%	-16.84%	+0.02%	+0.66%	-9.24%	-2.57%	+62.84%	+29.05%	-31.45%	+135.58%	-15.85%	+176.62%	+446.10%	n/a	n/a